Nanopore sequencing of native adeno-associated virus genomes to aid in gene therapy vector quality control

Sequencing of full-length native AAV genomes on Nanopore devices allows identification of truncation hotspots, plasmid and cell line contamination, and mutation hotspots

Download the poster to find out more about:

  • How adeno-associated virus (AAV) is used for gene therapy
  • How the EPI2METM Labs’ wf-clone-validation' workflow can be used to validate AAV plasmid constructs
  • How full-length native AAV genomes and vector contamination are identified with nanopore sequencing
  • How to generate consensus sequences and identify truncation hotspots

Download the PDF